Penggunaan Produk Biosimilar pada Transplantasi Ginjal

  • Ardi L
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Transplantasi ginjal sering menimbulkan rejeksi, oleh karenanya diperlukan obat-obatan imunosupresan sebelum, saat, dan setelah transplantasi ginjal. Terapi imunosupresan pada transplantasi ginjal terdiri dari terapi induksi, pemeliharaan awal, dan pemeliharaan jangka panjang. Beberapa produk biosimilar dapat digunakan untuk terapi rejeksi pada transplantasi ginjal. Kidney transplantation often results in rejection; it is necessary to give immunosuppressant drugs before, during, and after kidney transplantation. Immunosuppressant therapy in kidney transplantation consists of induction therapy, early maintenance, and long-term maintenance. Several biosimilar products can be used for immunosuppressant in kidney transplants.

Cite

CITATION STYLE

APA

Ardi, L. (2021). Penggunaan Produk Biosimilar pada Transplantasi Ginjal. Cermin Dunia Kedokteran, 48(11), 365. https://doi.org/10.55175/cdk.v48i11.1559

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free